Qiagen shares: optimism in biotech
—·3h
After four years of price decline, a renewal at the test specialist is becoming increasingly urgent - a takeover is also possible.
ChannelsstocksCountriesgermany, europeCategoriesmergers-acquisitions
Open original source ↗Published
7/17/2026, 1:00:00 PM
Fetched
7/17/2026, 3:08:28 PM
Confidence
60 / 100
Relevance
42 / 100
Trust
—
Language
de